STOCK TITAN

Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Inspire Medical Systems (NYSE: INSP) announced its management will present at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026 at 1:30 p.m. ET. The presentation will be available via live webcast and a replay will be posted for two weeks in the Event Archive.

Investors can access the live webcast and the two-week replay on Inspire’s investor website Event Archive at the provided URL.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – INSP

+1.53%
1 alert
+1.53% News Effect

On the day this news was published, INSP gained 1.53%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference date: March 17, 2026 Presentation time: 1:30 p.m. Eastern Time Webcast replay length: Two weeks
3 metrics
Conference date March 17, 2026 KeyBanc Capital Markets Healthcare Forum presentation date
Presentation time 1:30 p.m. Eastern Time Scheduled time for KeyBanc forum presentation
Webcast replay length Two weeks Replay availability period on Investor website

Market Reality Check

Price: $65.80 Vol: Volume 1,470,163 is below...
normal vol
$65.80 Last Close
Volume Volume 1,470,163 is below the 20-day average of 1,591,895. normal
Technical Price 64.81 is trading below the 200-day MA at 100.42, and 65.8% below the 52-week high.

Peers on Argus

INSP gained 0.47% while key medical device peers like ATEC, HAE, PRCT, QDEL, and...

INSP gained 0.47% while key medical device peers like ATEC, HAE, PRCT, QDEL, and LIVN also showed positive moves, but no peers appeared in the momentum scanner, suggesting today’s move is more stock-specific than a broad sector rotation.

Historical Context

5 past events · Latest: Feb 11 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Feb 11 Earnings results Positive -12.6% Reported strong 4Q25 and FY25 financial results and updated 2026 guidance.
Jan 12 Prelim revenue Positive -1.5% Issued preliminary Q4 and FY25 revenue and initial 2026 revenue guidance.
Jan 07 Earnings date set Neutral +1.9% Announced date and time for 4Q25 and FY25 financial results call.
Dec 29 Conference presentation Neutral -1.9% Disclosed presentation plans for the 44th Annual J.P. Morgan Healthcare Conference.
Nov 18 Conference presentation Neutral -1.5% Announced participation in the Piper Sandler 37th Annual Healthcare Conference.
Pattern Detected

Recent history shows positive earnings-related news followed by negative price reactions, while conference and presentation announcements have been associated with relatively modest moves.

Recent Company History

Over the last few months, INSP reported strong 4Q25 and FY25 results on Feb 11, 2026, including higher revenue and EPS, yet the stock fell 12.55%. Preliminary unaudited revenue and upbeat 2026 guidance on Jan 12, 2026 also saw a 1.47% decline. By contrast, announcements about upcoming earnings dates and presentations at major conferences like J.P. Morgan and Piper Sandler led to smaller, mixed price reactions, framing today’s KeyBanc forum appearance as part of an ongoing investor outreach cadence.

Market Pulse Summary

This announcement adds another investor-relations touchpoint, with management presenting at the KeyB...
Analysis

This announcement adds another investor-relations touchpoint, with management presenting at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026 at 1:30 p.m. Eastern Time. It follows a series of conference appearances and recent earnings updates, including notable price reactions around the Feb 11, 2026 results. Investors may focus on any new commentary around growth drivers, reimbursement dynamics, and recent operational trends, with the two-week webcast replay offering additional opportunity to review management’s messaging.

Key Terms

obstructive sleep apnea, webcast
2 terms
obstructive sleep apnea medical
"solutions for patients with obstructive sleep apnea, announced today that its"
Obstructive sleep apnea is a common medical condition where the throat repeatedly narrows or closes during sleep, causing short pauses in breathing, drops in blood oxygen and fragmented rest. It matters to investors because it creates ongoing demand for medical devices, diagnostics, treatments and sleep-monitoring services, and it can affect population health, workforce productivity and healthcare spending—like a recurring leak in a system that requires continual repair and monitoring.
webcast technical
"The presentation will be accessible via a live webcast here."
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

MINNEAPOLIS, March 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026.

Inspire is scheduled to present at 1:30 p.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443


FAQ

When will Inspire Medical Systems (INSP) present at the KeyBanc Healthcare Forum on March 17, 2026?

Inspire will present on March 17, 2026 at 1:30 p.m. Eastern Time. According to Inspire Medical Systems, management will deliver the presentation live and answer prepared remarks relevant to investors.

How can investors watch the INSP presentation at the KeyBanc forum on March 17, 2026?

Investors can watch a live webcast of the presentation via Inspire’s investor website. According to Inspire Medical Systems, the live webcast link will be available on the company’s Event Archive page.

Will there be a replay of Inspire Medical Systems (INSP) presentation after March 17, 2026?

Yes; a webcast replay will be available for two weeks following the presentation. According to Inspire Medical Systems, the replay will be posted in the Event Archive on the investor website.

Where is the replay of the INSP KeyBanc presentation hosted after March 17, 2026?

The replay is hosted in the Event Archive on Inspire’s investor website. According to Inspire Medical Systems, the replay will remain accessible for two weeks after the live presentation.

What topics will Inspire Medical Systems (INSP) cover at the KeyBanc Capital Markets Healthcare Forum?

The company will present management’s update and corporate overview during its scheduled slot. According to Inspire Medical Systems, the presentation focuses on recent developments and investor-relevant corporate information.
Inspire Medical

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Latest SEC Filings

INSP Stock Data

1.85B
28.05M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GOLDEN VALLEY